Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines in the United Kingdom. Its lead drug candidate consists of OCT461201, a cannabinoid like new chemical entity, which is in phase I clinical trial for potential therapy to peripheral neuropathies and irritable bowel syndrome.… Read more
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) - Total Liabilities
Latest total liabilities as of October 2023: $840.00K USD
Based on the latest financial reports, Oxford Cannabinoid Technologies Holdings Plc (OCTHF) has total liabilities worth $840.00K USD as of October 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Oxford Cannabinoid Technologies Holdings Plc - Total Liabilities Trend (2018–2023)
This chart illustrates how Oxford Cannabinoid Technologies Holdings Plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Oxford Cannabinoid Technologies Holdings Plc Competitors by Total Liabilities
The table below lists competitors of Oxford Cannabinoid Technologies Holdings Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hwa Tai Industries Bhd
KLSE:8478
|
Malaysia | RM73.25 Million |
|
Hanil Vacuum Co. Ltd
KQ:123840
|
Korea | ₩47.76 Billion |
|
Dangee Dums Limited
NSE:DANGEE
|
India | ₹220.53 Million |
|
PExA AB (publ)
F:FA0
|
Germany | €2.07 Million |
|
X2M Connect Ltd
AU:X2M
|
Australia | AU$9.26 Million |
|
Talis Biomedical Corp
PINK:TLIS
|
USA | $24.07 Million |
Liability Composition Analysis (2018–2023)
This chart breaks down Oxford Cannabinoid Technologies Holdings Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oxford Cannabinoid Technologies Holdings Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oxford Cannabinoid Technologies Holdings Plc (2018–2023)
The table below shows the annual total liabilities of Oxford Cannabinoid Technologies Holdings Plc from 2018 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-04-30 | $583.92K | -71.17% |
| 2022-04-30 | $2.03 Million | +102.93% |
| 2021-04-30 | $998.00K | +27.93% |
| 2020-04-30 | $780.13K | +42.96% |
| 2019-04-30 | $545.70K | -13.79% |
| 2018-04-30 | $632.97K | -- |